<SEC-DOCUMENT>0000950103-25-014144.txt : 20251103
<SEC-HEADER>0000950103-25-014144.hdr.sgml : 20251103
<ACCEPTANCE-DATETIME>20251103145847
ACCESSION NUMBER:		0000950103-25-014144
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20251103
DATE AS OF CHANGE:		20251103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251443606

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251443607

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp236808_424b2-us2524132d.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 53%; font-size: 10pt; color: #888888"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
    <TD STYLE="width: 47%">
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">October 30, 2025</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Medium-Term Senior Notes, Series
    N</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Pricing Supplement No. 2025-USNCH29100</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement Nos. 333-270327
    and 333-270327-01</P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P></TD></TR>
  </TABLE>
<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 11pt">Autocallable Securities
Linked to the Worst Performing of Delta Air Lines, Inc. and NVIDIA Corporation Due November 2, 2028</FONT></P>

<P STYLE="color: #59AE43; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 2.15pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>The securities offered by this pricing supplement are unsecured debt securities issued by Citigroup Global Markets Holdings Inc. and
guaranteed by Citigroup Inc. Unlike conventional debt securities, the securities do not pay interest, do not guarantee the repayment of
principal at maturity and are subject to potential automatic early redemption on a periodic basis on the terms described below. Your return
on the securities will depend solely on the performance of the <B>worst performing</B> of the underlyings specified below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 2.15pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>The securities offer the potential for automatic early redemption at a premium following the first valuation date (other than the
final valuation date) on which the closing value of the worst performing underlying on that valuation date is greater than or equal to
its then-applicable premium threshold value. If the securities are not automatically redeemed prior to maturity, the securities will provide
for repayment of the stated principal amount <I>plus</I> a premium at maturity if the final underlying value of the worst performing underlying
on the final valuation date is greater than or equal to its final barrier value. <B>However, if the securities are not automatically redeemed
prior to maturity and the final underlying value of the worst performing underlying on the final valuation date is less than its final
barrier value, you will not be repaid the stated principal amount of your securities at maturity and, instead, will receive a fixed number
of underlying shares of the worst performing underlying on the final valuation date equal to its equity ratio specified below (or, in
our sole discretion, the cash value of those shares based on its final underlying value) that will be worth significantly less than the
stated principal amount of your securities and possibly nothing.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 2.15pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>You will be subject to risks associated with <U>each</U> of the underlyings and will be negatively affected by adverse movements in
<U>any one</U> of the underlyings. Although you will have downside exposure to the worst performing underlying on the final valuation
date, you will not receive dividends with respect to any underlying or participate in any appreciation of any underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 2.15pt"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>Investors in the securities must be willing to accept (i) an investment that may have limited or no liquidity and (ii) the risk of
not receiving any payments due under the securities if we and Citigroup Inc. default on our obligations. <B>All payments on the securities
are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issuer:</B></FONT></TD>
    <TD STYLE="width: 80%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Guarantee:</B></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlyings:</TD>
    <TD STYLE="width: 20%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Initial underlying value<SUP>*</SUP></B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final barrier value<SUP>**</SUP></B></FONT></TD>
    <TD STYLE="width: 20%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Equity ratio<SUP>***</SUP></B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Delta Air Lines, Inc.</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$57.12</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$28.560&#9;</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&#9;17.50700&#9;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">NVIDIA Corporation</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$202.89&#9;</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$101.445</FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">4.92878</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>*</SUP>For each underlying, its closing value on the pricing date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>**</SUP>For each underlying, 50.00% of its initial underlying value</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>***</SUP>For each underlying, the stated principal amount <I>divided
by</I> its initial underlying value</P>

</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Stated principal amount:</B></FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-size: 10pt; color: Black">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Pricing date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">October 30, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">November 4, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Maturity date:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Unless earlier redeemed, November 2, 2028</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Automatic early redemption:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">If, on any valuation date prior to the final valuation date, the closing value of the worst performing underlying on that valuation date is greater than or equal to its then-applicable premium threshold value, the securities will be automatically redeemed on the third business day immediately following that valuation date for an amount in cash per security equal to $1,000 <I>plus</I> the premium applicable to that valuation date. If the securities are automatically redeemed following any valuation date prior to the final valuation date, they will cease to be outstanding and you will not receive the premium applicable to any later valuation date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Payment at maturity:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the securities are not automatically redeemed prior to maturity,
    you will receive at maturity for each security you then hold:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"><FONT STYLE="font-family: Wingdings">&sect;</FONT>
    If the final underlying value of the worst performing underlying on the final valuation date is <B>greater than or equal to</B> its final
    barrier value: $1,000 + the premium applicable to the final valuation date</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"><FONT STYLE="font-family: Wingdings">&sect;</FONT>
    If the final underlying value of the worst performing underlying on the final valuation date is <B>less than</B> its final barrier value:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt">a fixed number of underlying shares of the worst performing
    underlying on the final valuation date equal to its equity ratio (or, if we elect, the cash value of those shares based on its final underlying
    value)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the securities are not automatically redeemed prior to maturity
    and the final underlying value of the worst performing underlying on the final valuation date is less than its final barrier value, you
    will receive underlying shares of the worst performing underlying on the final valuation date (or, in our sole discretion, cash) that
    will be worth significantly less than the stated principal amount of your securities, and possibly nothing, at maturity.</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Listing:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriter:</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;), an affiliate of the issuer, acting as principal</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD STYLE="width: 26%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 28%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Proceeds to issuer<SUP>(3)</SUP></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Per security:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$29.50</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$970.50</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Total:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$29,500.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$970,500.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><I>(Key Terms continued on next page)</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(1) On the date of this pricing supplement, the estimated value of the
securities is $917.50 per security, which is less than the issue price. The estimated value of the securities is based on CGMI&rsquo;s
proprietary pricing models and our internal funding rate. It is not an indication of actual profit to CGMI or other of our affiliates,
nor is it an indication of the price, if any, at which CGMI or any other person may be willing to buy the securities from you at any time
after issuance. See &ldquo;Valuation of the Securities&rdquo; in this pricing supplement.</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(2) CGMI will receive an underwriting fee of up to $29.50 for each security
sold in this offering. The total underwriting fee and proceeds to issuer in the table above give effect to the actual total underwriting
fee. For more information on the distribution of the securities, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement.
In addition to the underwriting fee, CGMI and its affiliates may profit from hedging activity related to this offering, even if the value
of the securities declines. See &ldquo;Use of Proceeds and Hedging&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(3) The per security proceeds to issuer indicated above represent the
minimum per security proceeds to issuer for any security, assuming the maximum per security underwriting fee. As noted above, the underwriting
fee is variable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-8.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of the securities or determined that this pricing
supplement and the accompanying product supplement, prospectus supplement and prospectus are truthful or complete. Any representation
to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>You should read this pricing supplement together
with the accompanying product supplement, prospectus supplement and prospectus, which can be accessed via the hyperlinks below:</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003818/dp190217_424b2-ea0210.htm" STYLE="color: rgb(89,174,67)"><FONT STYLE="color: #59AE43"><B>Product Supplement No. EA-02-10 dated March 7, 2023</B></FONT></A>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;<A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(89,174,67)"><FONT STYLE="color: #59AE43"><B>Prospectus Supplement and Prospectus each dated March 7, 2023</B></FONT></A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS (continued)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 23%"><FONT STYLE="color: #59AE43"><B>Valuation dates and premiums:</B></FONT></TD>
    <TD STYLE="width: 77%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The valuation dates and the premium applicable to each valuation
date are set forth below. <B>The premium may be significantly less than the appreciation of any underlying from the pricing date to the
applicable valuation date.</B></P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 23%">&nbsp;</TD>
    <TD STYLE="width: 38%; padding-left: 23.8pt"><B>Valuation Date*</B></TD>
    <TD STYLE="width: 39%; padding-left: 56.8pt"><B>Premium</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 23.8pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>April 30, 2026</TD>
    <TD>6.0250% of the stated principal amount</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 23.8pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>July 30, 2026</TD>
    <TD>9.0375% of the stated principal amount</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 23.8pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>October 30, 2026</TD>
    <TD>12.0500% of the stated principal amount</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 23.8pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>February 1, 2027</TD>
    <TD>15.0625% of the stated principal amount</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 23.8pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>April 30, 2027</TD>
    <TD>18.0750% of the stated principal amount</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 23.8pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>July 30, 2027</TD>
    <TD>21.0875% of the stated principal amount</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 23.8pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>November 1, 2027</TD>
    <TD>24.1000% of the stated principal amount</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 23.8pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>January 31, 2028</TD>
    <TD>27.1125% of the stated principal amount</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 23.8pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>May 1, 2028</TD>
    <TD>30.1250% of the stated principal amount</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 23.8pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>July 31, 2028</TD>
    <TD>33.1375% of the stated principal amount</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-left: 23.8pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>October 30, 2028 (the &ldquo;final &#9;valuation date&rdquo;)</TD>
    <TD STYLE="vertical-align: bottom">36.1500% of the stated principal amount</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>*Each valuation date is subject to postponement if such date is not
a scheduled trading day or certain market disruption events occur.</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD STYLE="width: 23%"><FONT STYLE="color: #59AE43"><B>Premium threshold value:</B></FONT></TD>
    <TD STYLE="width: 77%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: white"><FONT STYLE="color: Black">For each underlying, the
premium threshold value applicable to each valuation date (other than the final valuation date) is the percentage of the initial underlying
value of such underlying set forth below.</FONT></P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="background-color: rgb(234,243,224)">
    <TD STYLE="width: 23%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 38%; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>April 30, 2026</TD>
    <TD STYLE="vertical-align: top; width: 39%">For each underlying, 100.00% of its initial underlying value</TD></TR>
  <TR STYLE="background-color: rgb(234,243,224)">
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>July 30, 2026</TD>
    <TD STYLE="vertical-align: top">For each underlying, 95.00% of its initial underlying value</TD></TR>
  <TR STYLE="background-color: rgb(234,243,224)">
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>October 30, 2026</TD>
    <TD STYLE="vertical-align: top">For each underlying, 90.00% of its initial underlying value</TD></TR>
  <TR STYLE="background-color: rgb(234,243,224)">
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>February 1, 2027</TD>
    <TD STYLE="vertical-align: top">For each underlying, 85.00% of its initial underlying value</TD></TR>
  <TR STYLE="background-color: rgb(234,243,224)">
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>April 30, 2027</TD>
    <TD STYLE="vertical-align: top">For each underlying, 80.00% of its initial underlying value</TD></TR>
  <TR STYLE="background-color: rgb(234,243,224)">
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>July 30, 2027</TD>
    <TD STYLE="vertical-align: top">For each underlying, 75.00% of its initial underlying value</TD></TR>
  <TR STYLE="background-color: rgb(234,243,224)">
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>November 1, 2027</TD>
    <TD STYLE="vertical-align: top">For each underlying, 70.00% of its initial underlying value</TD></TR>
  <TR STYLE="background-color: rgb(234,243,224)">
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>January 31, 2028</TD>
    <TD STYLE="vertical-align: top">For each underlying, 65.00% of its initial underlying value</TD></TR>
  <TR STYLE="background-color: rgb(234,243,224)">
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>May 1, 2028</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">For each underlying, 60.00% of its initial underlying value</FONT></TD></TR>
  <TR STYLE="background-color: rgb(234,243,224)">
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>July 31, 2028</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">For each underlying, 55.00% of its initial underlying value</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="width: 23%"><FONT STYLE="color: #59AE43"><B>Final underlying value:</B></FONT></TD>
    <TD STYLE="width: 77%"><FONT STYLE="color: Black">For each underlying, its closing value on the final valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD><FONT STYLE="color: #59AE43"><B>Worst performing underlying:</B></FONT></TD>
    <TD>For any valuation date, the underlying with the lowest underlying return determined as of that valuation date</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="color: #59AE43"><B>Underlying return:</B></FONT></TD>
    <TD>For each underlying on any valuation date, (i) its closing value on that valuation date <I>minus</I> its initial underlying value, <I>divided by</I> (ii) its initial underlying value</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(234,243,224)">
    <TD><FONT STYLE="color: #59AE43"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD>17331BVT3 / US17331BVT33</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Additional Information</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>General.</B> The terms of the securities are set forth in the accompanying
product supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement. The accompanying product supplement,
prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, the
accompanying product supplement contains important information about how the closing value of each underlying will be determined and about
adjustments that may be made to the terms of the securities upon the occurrence of market disruption events and other specified events
with respect to each underlying. It is important that you read the accompanying product supplement, prospectus supplement and prospectus
together with this pricing supplement in connection with your investment in the securities. Certain terms used but not defined in this
pricing supplement are defined in the accompanying product supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Closing Value.</B> The &ldquo;closing value&rdquo; of each underlying
on any date is the closing price of its underlying shares on such date, as provided in the accompanying product supplement. The &ldquo;underlying
shares&rdquo; of the underlyings are their respective shares of common stock. Please see the accompanying product supplement for more
information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Hypothetical Payment Upon Automatic Early Redemption</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following table illustrates how the amount payable per security
upon automatic early redemption will be calculated if the closing value of the worst performing underlying on any valuation date prior
to the final valuation date is greater than or equal to its then-applicable premium threshold value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 34%"><FONT STYLE="font-size: 10pt"><B>If the closing value of the worst performing underlying on the following valuation date&hellip;</B></FONT></TD>
    <TD STYLE="width: 31%"><FONT STYLE="font-size: 10pt"><B>&hellip;is greater than or equal to the following premium threshold value&hellip;</B></FONT></TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-size: 10pt"><B>&hellip;then you will receive the following payment per $1,000 security upon automatic early redemption:</B></FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">1<SUP>st</SUP> valuation date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">100.00% of the initial underlying value</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $60.250 = $1,060.250</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">2<SUP>nd</SUP> valuation date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">95.00% of the initial underlying value</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $90.375 = $1,090.375</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">3<SUP>rd</SUP> valuation date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">90.00% of the initial underlying value</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $120.500 = $1,120.500</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">4<SUP>th</SUP> valuation date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">85.00% of the initial underlying value</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $150.625 = $1,150.625</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">5<SUP>th</SUP> valuation date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">80.00% of the initial underlying value</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $180.750 = $1,180.750</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">6<SUP>th</SUP> valuation date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">75.00% of the initial underlying value</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $210.875 = $1,210.875</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">7<SUP>th</SUP> valuation date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">70.00% of the initial underlying value</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $241.000 = $1,241.000</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">8<SUP>th</SUP> valuation date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">65.00% of the initial underlying value</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $271.125 = $1,271.125</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">9<SUP>th</SUP> valuation date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">60.00% of the initial underlying value</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $301.250 = $1,301.250</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">10<SUP>th</SUP> valuation date</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">55.00% of the initial underlying value</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$1,000 + applicable premium = $1,000 + $331.375 = $1,331.375</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If, on any valuation date prior to the final valuation date, the
closing value of any underlying is less than its then-applicable premium threshold value, you will not receive the premium indicated above
following that valuation date. In order to receive the premium indicated above, the closing value of <I>each</I> underlying on the applicable
valuation date must be greater than or equal to its then-applicable premium threshold value.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Payment at Maturity Diagram</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The diagram below illustrates the value of what you would receive at
maturity of the securities, assuming the securities have not previously been automatically redeemed, for a range of hypothetical underlying
returns of the worst performing underlying on the final valuation date. Your payment at maturity (if the securities are not earlier automatically
redeemed) will be determined based solely on the performance of the worst performing underlying on the final valuation date. For purposes
of the diagram, the value of any underlying shares you receive at maturity is based on the final underlying value of the worst performing
underlying on the final valuation date, which is the closing value on the final valuation date of the worst performing underlying on that
valuation date. On the maturity date, the value of any underlying shares you receive may differ from their value on the final valuation
date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investors in the securities will not receive any dividends with respect
to the underlyings. The diagram and examples below do not show any effect of lost dividend yield over the term of the securities.</B>
See &ldquo;Summary Risk Factors&mdash;You will not receive dividends or have any other rights with respect to the underlyings unless and
until you receive underlying shares at maturity&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD COLSPAN="2" STYLE="border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Payment at Maturity</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-right: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 294px; width: 398px"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; border-left: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: right"><FONT STYLE="font-family: Wingdings; color: #59AE43">n</FONT> The Securities</TD>
    <TD STYLE="width: 55%; border-bottom: #59AE43 1pt solid; border-right: #59AE43 1pt solid; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">n</FONT> The Worst Performing Underlying on the Final Valuation Date</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Hypothetical Examples of the Payment at Maturity</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are intended to illustrate how, if the securities
are not automatically redeemed prior to maturity, your payment at maturity will depend on the final underlying value of the worst performing
underlying on the final valuation date. Your actual payment at maturity per security, if the securities are not automatically redeemed
prior to maturity, will depend on the actual final underlying value of the worst performing underlying on the final valuation date. The
examples are solely for illustrative purposes, do not show all possible outcomes and are not a prediction of any payment that may be made
on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on the following hypothetical values and
do not reflect the actual initial underlying values, final barrier values or equity ratios of the underlyings. For the actual initial
underlying value, final barrier value and equity ratio of each underlying, see the cover page of this pricing supplement. We have used
these hypothetical values, rather than the actual values, to simplify the calculations and aid understanding of how the securities work.
However, you should understand that what you actually receive at maturity will be determined based on the actual initial underlying value,
final barrier value and equity ratio of each underlying, and not the hypothetical values indicated below. For ease of analysis, figures
below have been rounded.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 24%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 26%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical initial underlying value</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical final barrier value</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical equity ratio</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Delta Air Lines, Inc.</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$100.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$50.00 (50.00% of its hypothetical initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">10.00000</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">NVIDIA Corporation</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$100.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$50.00 (50.00% of its hypothetical initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">10.00000</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1&mdash;Upside Scenario A.</B> The final underlying value
of the worst performing underlying on the final valuation date is $110.00, resulting in a 10.00% underlying return for the worst performing
underlying on the final valuation date. In this example, the final underlying value of the worst performing underlying on the final valuation
date is <B>greater than</B> its final barrier value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 85%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 34%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical final underlying value</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical underlying return</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Delta Air Lines, Inc.*</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$110.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">10.00%</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">NVIDIA Corporation</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$135.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">35.00%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Worst performing underlying on the final valuation date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + the premium applicable to
the final valuation date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + $361.50</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,361.50</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, because the final underlying value of the worst performing
underlying on the final valuation date is greater than its final barrier value, you would be repaid the stated principal amount of your
securities at maturity <I>plus</I> the premium applicable to the final valuation date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2&mdash;Upside Scenario B.</B> The final underlying value
of the worst performing underlying on the final valuation date is $160.00, resulting in a 60.00% underlying return for the worst performing
underlying on the final valuation date. In this example, the final underlying value of the worst performing underlying on the final valuation
date is <B>greater than</B> its final barrier value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 85%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 34%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical final underlying value</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical underlying return</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Delta Air Lines, Inc.</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$170.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">70.00%</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">NVIDIA Corporation*</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$160.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">60.00%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Worst performing underlying on the final valuation date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = $1,000 + the premium applicable to
the final valuation date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + $361.50</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,361.50</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, because the final underlying value of the worst performing
underlying on the final valuation date is greater than its final barrier value, you would be repaid the stated principal amount of your
securities at maturity <I>plus</I> the premium applicable to the final valuation date. An investment in the securities would underperform
a hypothetical alternative investment providing 1-to-1 exposure to the appreciation of the worst performing underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3&mdash;Downside Scenario A.</B> The final underlying value
of the worst performing underlying on the final valuation date is $30.00, resulting in a -70.00% underlying return for the worst performing
underlying on the final valuation date. In this example, the final underlying value of the worst performing underlying on the final valuation
date is <B>less than</B> its final barrier value. Accordingly, at maturity, you would receive for each security you then hold a fixed
number of underlying shares of the worst performing underlying on the final valuation date equal to its equity ratio (or, at our option,
the cash value thereof).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 85%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 34%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical final underlying value</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical underlying return</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Delta Air Lines, Inc.*</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$30.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">-70.00%</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">NVIDIA Corporation</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$110.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">10.00%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Worst performing underlying on the final valuation date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the value of a number of underlying shares of the
worst performing underlying on the final valuation date equal to its equity ratio, based on its final underlying value, would be $300.00.
Therefore, the value of the underlying shares of the worst performing underlying on the final</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">valuation date (or, in our discretion, cash) you receive at maturity
would be significantly less than the stated principal amount of your securities. You would incur a loss based on the performance of the
worst performing underlying on the final valuation date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the final underlying value of the worst performing underlying on
the final valuation date is less than its final barrier value, we will have the option to deliver to you on the maturity date either a
number of underlying shares of the worst performing underlying on the final valuation date equal to its equity ratio or the cash value
of those underlying shares based on their final underlying value. The value of those underlying shares on the maturity date may be different
than their final underlying value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 4&mdash;Downside Scenario B.</B> The final underlying value
of the worst performing underlying on the final valuation date is $0.00, resulting in a -100.00% underlying return for the worst performing
underlying on the final valuation date. In this example, the final underlying value of the worst performing underlying on the final valuation
date is <B>less than</B> its final barrier value.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 85%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 34%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical final underlying value</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical underlying return</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Delta Air Lines, Inc.</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$105.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">5.00%</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">NVIDIA Corporation*</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">$0.00</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">-100.00%</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* Worst performing underlying on the final valuation date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, the underlying shares of the worst performing underlying
are worthless on the valuation date and, as a result, you would lose your entire investment in the securities at maturity. <B>It is possible
that the final underlying value of the worst performing underlying will be less than its final barrier value, such that you will receive
significantly less than the stated principal amount of your securities, and possibly nothing, at maturity.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Summary Risk Factors</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities. The securities are subject to all of the risks associated with an investment in our conventional debt
securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the securities,
and are also subject to risks associated with each underlying. Accordingly, the securities are suitable only for investors who are capable
of understanding the complexities and risks of the securities. You should consult your own financial, tax and legal advisors as to the
risks of an investment in the securities and the suitability of the securities in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities. You should read this summary together with the more detailed description of risks relating to an investment in the
securities contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement. You should also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated
by reference in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent
Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may lose a significant portion or all of your investment.</B> Unlike conventional debt securities, the securities do not provide
for the repayment of the stated principal amount at maturity in all circumstances. If the securities are not automatically redeemed prior
to maturity, your payment at maturity will depend on the final underlying value of the worst performing underlying on the final valuation
date. If the final underlying value of the worst performing underlying on the final valuation date is less than its final barrier value,
you will not receive the stated principal amount of your securities at maturity and, instead, will receive underlying shares of the worst
performing underlying on the final valuation date (or, in our sole discretion, cash based on its final underlying value) that will be
worth significantly less than the stated principal amount and possibly nothing. There is no minimum payment at maturity on the securities,
and you may lose up to all of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">We may elect, in our sole discretion, to
pay you cash at maturity in lieu of delivering any underlying shares of the worst performing underlying on the final valuation date. If
we elect to pay you cash at maturity in lieu of delivering any underlying shares of the worst performing underlying on the final valuation
date, the amount of that cash may be less than the market value on the maturity date of the underlying shares of the worst performing
underlying on the final valuation date because the market value will likely fluctuate between the final valuation date and the maturity
date. Conversely, if we do not exercise our cash election right and instead deliver underlying shares of the worst performing underlying
on the final valuation date to you on the maturity date, the market value of such underlying shares may be less than the cash amount you
would have received if we had exercised our cash election right. We will have no obligation to take your interests into account when deciding
whether to exercise our cash election right.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Your potential return on the securities is limited.</B> Your potential return on the securities is limited to the applicable premium
payable upon automatic early redemption or at maturity, as described on the cover page of this pricing supplement. If the closing value
of the worst performing underlying on one of the valuation dates is greater than or equal to its then-applicable premium threshold value
or final barrier value, you will be repaid the stated principal amount of your securities and will receive the fixed premium applicable
to that valuation date, regardless of how significantly the closing value of the worst performing underlying on that valuation date may
exceed its initial underlying value. Accordingly, any premium may result in a return on the securities that is significantly less than
the return you could have achieved on a direct investment in any or all of the underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities do not pay interest.</B> Unlike conventional debt securities, the securities do not pay interest prior to maturity.
You should not invest in the securities if you seek current income during the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to heightened risk because they have multiple underlyings.</B> The securities are more risky than similar
investments that may be available with only one underlying. With multiple underlyings, there is a greater chance that any one underlying
will perform poorly, adversely affecting your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the risks of each of the underlyings and will be negatively affected if any one underlying performs
poorly.</B> You are subject to risks associated with each of the underlyings. If any one underlying performs poorly, you will be negatively
affected. The securities are not linked to a basket composed of the underlyings, where the blended performance of the underlyings would
be better than the performance of the worst performing underlying alone. Instead, you are subject to the full risks of whichever of the
underlyings is the worst performing underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not benefit in any way from the performance of any better performing underlying.</B> The return on the securities depends
solely on the performance of the worst performing underlying, and you will not benefit in any way from the performance of any better performing
underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will be subject to risks relating to the relationship between the underlyings.</B> It is preferable from your perspective for
the underlyings to be correlated with each other, in the sense that their closing values tend to increase or decrease at similar times
and by similar magnitudes. By investing in the securities, you assume the risk that the underlyings will not exhibit this relationship.
The less correlated the underlyings, the more likely it is that any one of the underlyings will perform poorly over the term of the securities.
All that is necessary for the securities to perform poorly is for one of the underlyings to perform poorly. It is impossible to predict
what the relationship between the underlyings will be over the term of the securities. The underlyings differ in significant ways and,
therefore, may not be correlated with each other.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities may be automatically redeemed prior to maturity, limiting the term of the securities.</B> If the closing value of
the worst performing underlying on any valuation date (other than the final valuation date) is greater than or equal to its then-applicable
premium threshold value, the securities will be automatically redeemed. If the securities are automatically redeemed following any valuation
date prior to the final valuation date, they will cease to be outstanding and you will not receive the premium applicable to any later
valuation date. Moreover, you may not be able to reinvest your funds in another investment that provides a similar yield with a similar
level of risk.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities offer downside exposure to the worst performing underlying, but no upside exposure to any underlying.</B> You will
not participate in any appreciation in the value of any underlying over the term of the securities. Consequently, your return on the securities
will be limited to the applicable premium payable upon an automatic early redemption or at maturity and may be significantly less than
the return on any underlying over the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not receive dividends or have any other rights with respect to the underlyings unless and until you receive underlying
shares of the worst performing underlying on the final valuation date at maturity.</B> You will not receive any dividends with respect
to the underlyings unless and until you receive underlying shares of the worst performing underlying on the final valuation date at maturity.
This lost dividend yield may be significant over the term of the securities. The payment scenarios described in this pricing supplement
do not show any effect of such lost dividend yield over the term of the securities. In addition, you will not have voting rights or any
other rights with respect to the underlyings. If any change to the underlying shares of the worst performing underlying on the final valuation
date is proposed, such as an amendment to that underlying&rsquo;s organizational documents, you will not have the right to vote on such
change, but you will be subject to such change in the event you receive underlying shares of the worst performing underlying on the final
valuation date at maturity. Any such change may adversely affect the market value of the underlying shares of the worst performing underlying
on the final valuation date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The performance of the securities will depend on the closing values of the underlyings solely on the valuation dates, which makes
the securities particularly sensitive to volatility in the closing values of the underlyings on or near the valuation dates.</B> Whether
the securities will be automatically redeemed prior to maturity will depend on the closing values of the underlyings solely on the valuation
dates (other than the final valuation date), regardless of the closing values of the underlyings on other days during the term of the
securities. If the securities are not automatically redeemed prior to maturity, what you receive at maturity will depend solely on the
closing value of the worst performing underlying on the final valuation date, and not on any other day during the term of the securities.
Because the performance of the securities depends on the closing values of the underlyings on a limited number of dates, the securities
will be particularly sensitive to volatility in the closing values of the underlyings on or near the valuation dates. You should understand
that the closing value of each underlying has historically been highly volatile.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B> If we default on
our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you
under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.</B> The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor must be prepared
to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI&rsquo;s proprietary pricing models and our internal funding
rate, is less than the issue price.</B> The difference is attributable to certain costs associated with selling, structuring and hedging
the securities that are included in the issue price. These costs include (i) any selling concessions or other fees paid in connection
with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of
the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection
with hedging our obligations under the securities. These costs adversely affect the economic terms of the securities because, if they
were lower, the economic terms of the securities would be more favorable to you. The economic terms of the securities are also likely
to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities. See
&ldquo;The estimated value of the securities would be lower if it were calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.</B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of, and correlation between, the closing values of
the underlyings, dividend yields on the underlyings and interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo;
views, and as an underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models
may prove to be wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities
set forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the securities
for other purposes, including for accounting purposes. You should not invest in the securities because of the estimated value of the securities.
Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities would be lower if it were calculated based on our secondary market rate.</B> The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which
we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any purchases of the securities
from you in the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate,
rather than our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs
associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity
needs and preferences. Our internal funding rate is not an interest rate that is payable on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject
to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined measure of our
creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted for discretionary
factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of the securities
based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing
supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our secondary market
rate, which will likely result in a lower value for the securities than if our internal funding rate were used. In addition, any secondary
market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount
of the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions.
As a result, it is likely that any secondary market price for the securities will be less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors.</B> The value of your securities
prior to maturity will fluctuate based on the closing values of the underlyings, the volatility of, and correlation between, the closing
values of the underlyings, dividend yields on the underlyings, interest rates generally, the time remaining to maturity and our and Citigroup
Inc.&rsquo;s creditworthiness, as reflected in our secondary market rate, among other factors described under &ldquo;Risk Factors Relating
to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The value of your securities prior to maturity will fluctuate based
on many unpredictable factors&rdquo; in the accompanying product supplement. Changes in the closing values of the underlyings may not
result in a comparable change in the value of your securities. You should understand that the value of your securities at any time prior
to maturity may be significantly less than the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.</B> The amount of this temporary upward
adjustment will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Securities&rdquo; in this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Our offering of the securities is not a recommendation of any underlying.</B> The fact that we are offering the securities does
not mean that we believe that investing in an instrument linked to the underlyings is likely to achieve favorable returns. In fact, as
we are part of a global financial institution, our affiliates may have positions (including short positions) in the underlyings or in
instruments related to the underlyings, and may publish research or express opinions, that in each case are inconsistent with an investment
linked to the underlyings. These and other activities of our affiliates may affect the closing values of the underlyings in a way that
negatively affects the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The closing value of an underlying may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.</B>
We have hedged our obligations under the securities through CGMI or other of our affiliates, who have taken positions in the underlyings
or in financial instruments related to the underlyings and may adjust such positions during the term of the securities. Our affiliates
also take positions in the underlyings or in financial instruments related to the underlyings on a regular basis (taking long or short
positions or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf of customers.
These activities could affect the closing values of the underlyings in a way that negatively affects the value of and your return on the
securities. They could also result in substantial returns for us or our affiliates while the value of the securities declines.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates&rsquo; business activities.</B>
Our affiliates engage in business activities with a wide range of companies. These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services. These activities could involve or affect the underlyings
in a way that negatively affects the value of and your return on the securities. They could also result in substantial returns for us
or our affiliates while the value of the securities declines. In addition, in the course of this business, we or our affiliates may acquire
non-public information, which will not be disclosed to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B> If
certain events occur during the term of the securities, such as market disruption events and other events with respect to an underlying,
CGMI, as calculation agent, will be required to make discretionary judgments that could significantly affect your return on the securities.
In making these judgments, the calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder
of the securities. See &ldquo;Risk Factors Relating to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The calculation
agent, which is an affiliate of ours, will make important determinations with respect to the securities&rdquo; in the accompanying product
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Even if an underlying pays a dividend that it identifies as special or extraordinary, no adjustment will be required under the
securities for that dividend unless it meets the criteria specified in the accompanying product supplement.</B> In general, an adjustment
will not be made under the terms of the securities for any cash dividend paid by an underlying unless the amount of the dividend per share,
together with any other dividends paid in the same quarter, exceeds the dividend paid per share in the most recent quarter by an amount
equal to at least 10% of the closing value of that underlying on the date of declaration of the dividend. Any dividend will reduce the
closing value of the underlying by the amount of the dividend per share. If an underlying pays any dividend for which an adjustment is
not made under the terms of the securities, holders of the securities will be adversely affected. See &ldquo;Description of the Securities&mdash;Certain
Additional Terms for Securities Linked to an Underlying Company or an Underlying ETF&mdash;Dilution and Reorganization Adjustments&mdash;Certain
Extraordinary Cash Dividends&rdquo; in the accompanying product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be adjusted for all events that may have a dilutive effect on or otherwise adversely affect the closing
value of an underlying.</B> For example, we will not make any adjustment for ordinary dividends or extraordinary dividends that do not
meet</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">the criteria described above, partial tender
offers or additional underlying share issuances. Moreover, the adjustments we do make may not fully offset the dilutive or adverse effect
of the particular event. Investors in the securities may be adversely affected by such an event in a circumstance in which a direct holder
of the underlying shares of an underlying would not.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities may become linked to an underlying other than an original underlying upon the occurrence of a reorganization event
or upon the delisting of the underlying shares of that original underlying.</B> For example, if an underlying enters into a merger agreement
that provides for holders of its underlying shares to receive shares of another entity and such shares are marketable securities, the
closing value of that underlying following consummation of the merger will be based on the value of such other shares. Additionally, if
the underlying shares of an underlying are delisted, the calculation agent may select a successor underlying. See &ldquo;Description of
the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying Company or an Underlying ETF&rdquo; in the accompanying
product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>If the underlying shares of an underlying are delisted, we may call the securities prior to maturity for an amount that may be
less than the stated principal amount.</B> If we exercise this call right, you will receive the amount described under &ldquo;Description
of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying Company or an Underlying ETF&mdash;Delisting of
an Underlying Company&rdquo; in the accompanying product supplement. This amount may be less, and possibly significantly less, than the
stated principal amount of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in th<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">e securities ar</FONT>e
unclear. </B> There is no direct legal authority regarding the proper U.S. federal tax treatment of the securities, and we do not plan
to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;). Consequently, significant aspects of the tax treatment
of the securities are uncertain, and the IRS or a court might not agree with the treatment of the securities as prepaid forward contracts.
If the IRS were successful in asserting an alternative treatment of the securities, the tax consequences of the ownership and disposition
of the securities might be materially and adversely affected. Moreover, future legislation, Treasury regulations or IRS guidance could
adversely affect the U.S. federal tax treatment of the securities, possibly retroactively.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">If you are a non-U.S. investor, you should
review the discussion of withholding tax issues in &ldquo;United States Federal Tax Considerations&mdash;Non-U.S. Holders&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">You should read carefully the discussion
under &ldquo;United States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying
product supplement and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement. You should also consult your
tax adviser regarding the U.S. federal tax consequences of an investment in the securities, as well as tax consequences arising under
the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Information About Delta Air Lines, Inc.</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Delta Air Lines, Inc. provides scheduled air transportation for passengers,
freight, and mail over a network of routes. The underlying shares of Delta Air Lines, Inc. are registered under the Securities Exchange
Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Information provided to or filed with the SEC by Delta Air Lines, Inc. pursuant
to the Exchange Act can be located by reference to the SEC file number 001-05424 through the SEC&rsquo;s website at http://www.sec.gov.
In addition, information regarding Delta Air Lines, Inc. may be obtained from other sources including, but not limited to, press releases,
newspaper articles and other publicly disseminated documents. The underlying shares of Delta Air Lines, Inc. trade on the New York Stock
Exchange under the ticker symbol &ldquo;DAL.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding Delta Air Lines, Inc. from
publicly available information and have not independently verified any information regarding Delta Air Lines, Inc. This pricing supplement
relates only to the securities and not to Delta Air Lines, Inc. We make no representation as to the performance of Delta Air Lines, Inc.
over the term of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. Delta Air Lines, Inc. is not involved in any way in this offering and has no obligation relating
to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of Delta Air Lines, Inc. on October 30, 2025 was $57.12.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of Delta Air Lines, Inc. for
each day such value was available from January 2, 2015 to October 30, 2025. We obtained the closing values from Bloomberg L.P., without
independent verification. If certain corporate transactions occurred during the historical period shown below, including, but not limited
to, spin-offs or mergers, then the closing values shown below for the period prior to the occurrence of any such transaction have been
adjusted by Bloomberg L.P. as if any such transaction had occurred prior to the first day in the period shown below. You should not take
historical closing values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Delta Air Lines, Inc. &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="color: white"><BR>
</FONT><FONT STYLE="color: #59AE43">January 2, 2015 to October 30, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Information About NVIDIA Corporation</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">NVIDIA Corporation is a full-stack computing infrastructure company
with data-center-scale offerings whose full-stack includes the CUDA programming model that runs on all of its graphics processing units
(GPUs), as well as domain-specific software libraries, software development kits and Application Programming Interfaces and whose data-center-scale
offerings include compute and networking solutions that can scale to tens of thousands of GPU-accelerated servers interconnected to function
as a single giant computer. The underlying shares of NVIDIA Corporation are registered under the Securities Exchange Act of 1934, as amended
(the &ldquo;Exchange Act&rdquo;). Information provided to or filed with the SEC by NVIDIA Corporation pursuant to the Exchange Act can
be located by reference to the SEC file number 000-23985 through the SEC&rsquo;s website at http://www.sec.gov. In addition, information
regarding NVIDIA Corporation may be obtained from other sources including, but not limited to, press releases, newspaper articles and
other publicly disseminated documents. The underlying shares of NVIDIA Corporation trade on the Nasdaq Global Select Market under the
ticker symbol &ldquo;NVDA.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have derived all information regarding NVIDIA Corporation from publicly
available information and have not independently verified any information regarding NVIDIA Corporation. This pricing supplement relates
only to the securities and not to NVIDIA Corporation. We make no representation as to the performance of NVIDIA Corporation over the term
of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities represent obligations of Citigroup Global Markets Holdings
Inc. (guaranteed by Citigroup Inc.) only. NVIDIA Corporation is not involved in any way in this offering and has no obligation relating
to the securities or to holders of the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of NVIDIA Corporation on October 30, 2025 was $202.89.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the closing value of NVIDIA Corporation for each
day such value was available from January 2, 2015 to October 30, 2025. We obtained the closing values from Bloomberg L.P., without independent
verification. If certain corporate transactions occurred during the historical period shown below, including, but not limited to, spin-offs
or mergers, then the closing values shown below for the period prior to the occurrence of any such transaction have been adjusted by Bloomberg
L.P. as if any such transaction had occurred prior to the first day in the period shown below. You should not take historical closing
values as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>NVIDIA Corporation &ndash; Historical Closing Values</B></FONT><B><FONT STYLE="color: white"><BR>
</FONT><FONT STYLE="color: #59AE43">January 2, 2015 to October 30, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">United States Federal Tax Considerations</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement. This discussion does not address the U.S. federal tax consequences of the
ownership or disposition of the underlying shares that you may receive at maturity. You should consult your tax adviser regarding the
U.S. federal tax consequences of the ownership and disposition of the underlying shares.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, which
is based on current market conditions, a security should be treated as a prepaid forward contract for U.S. federal income tax purposes.
By purchasing a security, you agree (in the absence of an administrative determination or judicial ruling to the contrary) to this treatment.
There is uncertainty regarding this treatment, and the IRS or a court might not agree with it.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the securities is respected and subject to
the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>You should not recognize taxable income over the term of the securities prior to maturity, other than pursuant to a sale or exchange.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or exchange of a security (including retirement at maturity for cash), you should recognize capital gain or loss equal
to the difference between the amount realized and your tax basis in the security. Such gain or loss should be long-term capital gain or
loss if you held the security for more than one year.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If you receive the underlying shares (and cash in lieu of any fractional shares) at maturity, you should not recognize gain or loss
with respect to the underlying shares received. Instead, you should have an aggregate tax basis in the underlying shares received (including
any fractional shares deemed received) equal to your basis in the securities. Your holding period for any underlying shares received should
start on the day after receipt. With respect to any cash received in lieu of a fractional share, you should recognize capital loss in
an amount equal to the difference between the amount of cash received in lieu of the fractional share and the portion of your tax basis
in the securities that is allocable to the fractional share.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We do not plan to request a ruling from the IRS regarding the treatment
of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership
and disposition of the securities, including the timing and character of income recognized. In addition, the U.S. Treasury Department
and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance.
Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury
regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences
of an investment in the securities, possibly with retroactive effect. You should consult your tax adviser regarding possible alternative
tax treatments of the securities and potential changes in applicable law.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Non-U.S. Holders</B>. Subject to the discussions below and in &ldquo;United
States Federal Tax Considerations&rdquo; in the accompanying product supplement, if you are a Non-U.S. Holder (as defined in the accompanying
product supplement) of the securities, you generally should not be subject to U.S. federal withholding or income tax in respect of any
amount paid to you with respect to the securities, provided that (i) income in respect of the securities is not effectively connected
with your conduct of a trade or business in the United States, and (ii) you comply with the applicable certification requirements.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As discussed under &ldquo;United States Federal Tax Considerations&mdash;Tax
Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m) of the Code and Treasury regulations promulgated
thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S. Underlying Equities&rdquo;) or indices that
include U.S. Underlying Equities. Section 871(m) generally applies to instruments that substantially replicate the economic performance
of one or more U.S. Underlying Equities, as determined based on tests set forth in the applicable Treasury regulations. However, the regulations,
as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.
Based on the terms of the securities and representations provided by us, our counsel is of the opinion that the securities should not
be treated as transactions that have a &ldquo;delta&rdquo; of one within the meaning of the regulations with respect to any U.S. Underlying
Equity and, therefore, should not be subject to withholding tax under Section 871(m).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A determination that the securities are not subject to Section 871(m)
is not binding on the IRS, and the IRS may disagree with this treatment. Moreover, Section 871(m) is complex and its application may depend
on your particular circumstances, including your other transactions. You should consult your tax adviser regarding the potential application
of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If withholding tax applies to the securities, we will not be required
to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement. The preceding discussion, when read in combination with that section,
constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning and disposing
of the securities. </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Supplemental Plan of Distribution</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of up to $29.50 for each security
sold in this offering. The actual underwriting fee will be equal to the selling concession provided to selected dealers, as described
in this paragraph. From this underwriting fee, CGMI will pay selected dealers not affiliated with CGMI a variable selling concession of
up to $29.50 for each security they sell. For the avoidance of doubt, any fees or selling concessions described in this pricing supplement
will not be rebated if the securities are automatically redeemed prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Valuation of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the securities prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately three months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the three-month
temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time. See &ldquo;Summary Risk
Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Validity of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Davis Polk &amp; Wardwell LLP, as special products
counsel to Citigroup Global Markets Holdings Inc., when the securities offered by this pricing supplement have been executed and issued
by Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against payment therefor,
such securities and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup Global Markets Holdings
Inc. and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency
and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability
(including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses
no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed
above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York, except that
such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In giving this opinion, Davis Polk &amp; Wardwell LLP has assumed the
legal conclusions expressed in the opinions set forth below of Alexia Breuvart, Secretary and General Counsel of Citigroup Global Markets
Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc. In addition, this opinion
is subject to the assumptions set forth in the letter of Davis Polk &amp; Wardwell LLP dated February 14, 2024, which has been filed as
an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has been duly authorized,
executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of the terms of the securities
nor the issuance and delivery of the securities and the related guarantee, nor the compliance by Citigroup Global Markets Holdings Inc.
and Citigroup Inc. with the terms of the securities and the related guarantee respectively, will result in a violation of any provision
of any instrument or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable, or any restriction
imposed by any court or governmental body having jurisdiction over Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Alexia Breuvart, Secretary and General Counsel of
Citigroup Global Markets Holdings Inc., (i) the terms of the securities offered by this pricing supplement have been duly established
under the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings Inc. has
duly authorized the issuance and sale of such securities and such authorization has not been modified or rescinded; (ii) Citigroup Global
Markets Holdings Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the indenture has been duly
authorized, executed and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery of such indenture and
of the securities offered by this pricing supplement by Citigroup Global Markets Holdings Inc., and the performance by Citigroup Global
Markets Holdings Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate of incorporation
or bylaws or other constitutive documents. This opinion is given as of the date of this pricing supplement and is limited to the laws
of the State of New York.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Alexia Breuvart, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Global Markets Holdings Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed
above. In such examination, she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures
(other than those of officers of Citigroup Global Markets Holdings Inc.), the authenticity of all</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 10pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">documents submitted to her or such persons as originals, the conformity
to original documents of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the
originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Karen Wang, Senior Vice President &ndash; Corporate
Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of Citigroup Inc. has
duly authorized the guarantee of such securities by Citigroup Inc. and such authorization has not been modified or rescinded; (ii) Citigroup
Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly authorized, executed
and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and the performance by Citigroup Inc. of its obligations
thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or other constitutive documents.
This opinion is given as of the date of this pricing supplement and is limited to the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Karen Wang, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed above. In such examination,
she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures (other than those of officers
of Citigroup Inc.), the authenticity of all documents submitted to her or such persons as originals, the conformity to original documents
of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Contact</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&copy; 2025 Citigroup Global Markets Inc. All rights reserved. Citi
and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout the
world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 50%; font-size: 10pt; color: #59AE43">&nbsp;</TD><TD STYLE="width: 50%; text-align: right; font-size: 10pt; color: #59AE43"><FONT STYLE="font-size: 10pt">PS-</FONT><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp236808_exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-03</xbrli:startDate>
          <xbrli:endDate>2025-11-03</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-03</xbrli:startDate>
          <xbrli:endDate>2025-11-03</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-03</xbrli:startDate>
          <xbrli:endDate>2025-11-03</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">1,000,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">138.10</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">1,000,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">138.10</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">138.10</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">1,000,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $F 8X# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7W^KA_Z[1_\ H0JS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9NMZ]IOAW37O\
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M-OFN'[M(YY8_Y&*V* "BBB@ HHHH **** "HE_X^Y/\ KFO\VJ6HE_X^Y/\
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M_$K6OB&$?VE'('W6D\DZ[I3DG:HR548QRNW@] 0:O:P^O7-Z7L+>\BE542V
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ME@?A3J5_-^TS^9C;O'EX_N[1U_'-)6#W("BBBD 4444 %%%% !1110 4444
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M!W=;7S+6&&*:XD,FUE61BJ[5P=Q^4D\C\:L#PQH@@6'^SH?+5MX'/7 &/<8
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M(G1,K+Y9?;R,\ 'MGG!QUP<5S UZ_>UT[R+VZ^WRP"06\\"A) &899@HW%\
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MLW6D6=Y?17<RN98PH&UR =KAUR!P<,,T44 5;7PQI5E?1W<%NR2H./G)!."
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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M#YD__/N/^_H_PH\R?_GW'_?T?X4 3?:+[_GM!_WY/_Q5'VB^_P">T'_?D_\
MQ50^9/\ \^X_[^C_  H\R?\ Y]Q_W]'^% $WVB^_Y[0?]^3_ /%4?:+[_GM!
M_P!^3_\ %5#YD_\ S[C_ +^C_"CS)_\ GW'_ ']'^% $WVB^_P">T'_?D_\
MQ5'VB^_Y[0?]^3_\54/F3_\ /N/^_H_PH\R?_GW'_?T?X4 3?:+[_GM!_P!^
M3_\ %4?:+[_GM!_WY/\ \54/F3_\^X_[^C_"CS)_^?<?]_1_A0!-]HOO^>T'
M_?D__%4?:+[_ )[0?]^3_P#%5#YD_P#S[C_OZ/\ "CS)_P#GW'_?T?X4 3?:
M+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 54/F3_P#/N/\ OZ/\*/,G_P"?<?\
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M\])O^_IH^SC_ )Z3?]_30!+147V<?\])O^_IH^SC_GI-_P!_30!+147V<?\
M/2;_ +^FC[./^>DW_?TT 2T5%]G'_/2;_OZ:/LX_YZ3?]_30!+147V<?\])O
M^_IH^SC_ )Z3?]_30!+147V<?\])O^_IH^SC_GI-_P!_30!+147V<?\ /2;_
M +^FC[./^>DW_?TT 2T5%]G'_/2;_OZ:/LX_YZ3?]_30!+147V<?\])O^_IH
M^SC_ )Z3?]_30!+147V<?\])O^_IH^SC_GI-_P!_30!+147V<?\ /2;_ +^F
MC[./^>DW_?TT 2T5%]G'_/2;_OZ:/LX_YZ3?]_30!+147V<?\])O^_IH^SC_
M )Z3?]_30!+147V<?\])O^_IH^SC_GI-_P!_30!+147V<?\ /2;_ +^FC[./
M^>DW_?TT 2T5%]G'_/2;_OZ:/LX_YZ3?]_30!+1!_P A2#_KE)_-*B^SC_GI
M-_W]-.M8Q'JL)#.V8I/O.3W7UH V**** "BBB@ HHHH QI_^0]<?]>T7_H4E
M25'/_P AZX_Z]HO_ $*2I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *(/^0I!_URD_FE%$'_ "%(/^N4G\TH U:*** "BBB@".XW
M?9Y-LOE$*3YF,[??!K$34+];>*1I58I'%*ZF, R"1R .O!  Z=ZWF574JP!4
MC!!Z$5$UI;/)%(T$;/%_JV*C*?3TH R+F;;X@N1Y<IQ;1<JF1]Z2G_:!_P \
M9_\ OW2S_P#(>N/^O:+_ -"DJ2@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/
M^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,_
M_?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC
M[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^
M>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__
M '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J
M6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"
M+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/
M^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,_
M_?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC
M[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^
M>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__
M '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J
M6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"+[0/^>,__?NC[0/^>,__ '[J6B@"
M+[0/^>,__?NC[0/^>,__ '[J6B@"!KI$4L\<JJ.I9, 4+=)(H9(Y64]"J9!K
MFO&]ZT=O;V:2,OFY:11T91T!_&M3PLP;PW9X_A#*?^^C6"K7JNGV,55O4=/L
M:?V@?\\9_P#OW1]H'_/&?_OW4M%;FQ%]H'_/&?\ []TZTDWZK#\DBXBD^^N.
MZT^B#_D*0?\ 7*3^:4 :M%%% !1110 44C,J*69@J@9))P!3/M$.8QYT?[S[
MGS#Y_IZT 94__(>N/^O:+_T*2I*CG_Y#UQ_U[1?^A25)0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !136D16"LZJ6Z D
MGZ4Z@ HHHH ,'&<45P?B#4;B#Q9FWFD3RC&-I8E<XYXZ=Z[P\&L:=53E)+H9
M4ZJFVET"BBLC4M<73]5LK'R=YN"-S9QL!.!]:TE-15Y%RDHJ[->BBBJ*"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P"?G_R&*EHH B\N;_GY_P#(8H\N;_GY_P#(8J6B@"+RYO\ GY_\ABCRYO\
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M=<+2( 9^"6 SRU=%Y\/_ #VB_P"^Q2P_\/[_ ,V*A\'W_FR2BH_/A_Y[1?\
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M )X)_P!_?_K4;[C_ )X)_P!_?_K4 2T5%ON/^>"?]_?_ *U&^X_YX)_W]_\
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M072;CY+$$ 9 ![G\0/SJIX:V:KXAO-0F@#%55E;/W'Z9Q] :YIW]HZ/1M/\
M5_D<\K\[I=W?]666T21?&RW*6C"R)\W>N H;'?\ &NJHHKOITU"]NKN=D*:A
M>W4*R_$&G3:II#VT#*)=RLH8X!P>F>U:E%5**E%Q?4J45).+*VG6QL]-MK8@
M!HHPK '(SCG]:LT44TK*R&E9605F^(4>3P_?*@R?*SUQP""?Y5I4V6-)HGBD
M4-&X*LI[@]J4X\T6NXI+FBT97A?/_"-V>?[K8_[Z-:]1V]O#:P)!!&(XDX5%
MZ"I*4(\L5%] A'EBD%$'_(4@_P"N4G\THH@_Y"D'_7*3^:591JT444 %%%%
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MU[1?^A25)4<__(>N/^O:+_T*2I* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .-\>?\N'TD_I
M61)<!4U9E9<RV\*^N1\N:V?':G%@W;YQ_*N/5B RKSO&,#ZUXF)ERUI?UT/(
MQ$K57_70U=5T1]/L[.X19766$/,V,JC'&!G\:ZOPA96\.CI=Q@^=.")"3QPQ
MP,5M>1'+9K!+&'C,85D8<$8[BGQ11P1+%$BI&HPJJ, "N^EAE"ISKL=M/#J$
M^9#Z***[#J"BBB@ HHHH **** "BBB@ HHHH 0*H8L%4$]2!R:6BB@ HHHH
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M^F$__?'_ ->IJ* (?M'_ $PG_P"^/_KT?:/^F$__ 'Q_]>IJ* (?M'_3"?\
M[X_^O1]H_P"F$_\ WQ_]>IJ* (?M'_3"?_OC_P"O1]H_Z83_ /?'_P!>IJ*
M(?M'_3"?_OC_ .O1]H_Z83_]\?\ UZFHH Q]7TZ/6%MUD6YC$,F_ B!W>QYK
MG_$%C''K^GO#;>3%*RJ(UC"Y(;GI]17<5#-:6US)%)- DCQ'=&S#E3ZBN>K0
MC-.V^GX&%2BIKST_ 4W&2?W$_P#WQ_\ 7I/M'_3"?_OC_P"O4U%=!N0_:/\
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MT 6:*K?VC8_\_P!:_P#?Y?\ &C^T;'_G^M?^_P O^- %FBJW]HV/_/\ 6O\
MW^7_ !H_M&Q_Y_K7_O\ +_C0!9HJM_:-C_S_ %K_ -_E_P :/[1L?^?ZU_[_
M "_XT 6:*K?VC8_\_P!:_P#?Y?\ &C^T;'_G^M?^_P O^- %FBJW]HV/_/\
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M $\XJQ0!DZ])YEO'I\:R-<7;8C".$QMPQ))SQP,C!SG&*BT/SA>WZWKR&_\
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M]WN)4L0=H.W&<5KL-RE<D9&,CK4%K8P6EI]EC4M&=Q;>=Q<L26))ZDDDGZT
M<=IS7\^M(;&\M[F197EEG_?8DA;=L4D_)V&-N?N\8KH]:M-0O$2.T-LL:_,S
M2@$YYX *,,?K4UOHMA:7IN[6'[/(P 81,55P,X!4<<9/:M"@#%\-QI::%DQ/
M$HDDD;>N-V6)+!=HP#U P*RT-Q(\-[+]HBTJ[NHIU'F*SAF90F>ZJ3M& 20#
MCIG'75GQ:)IT$R2QV^#&VY%+L40^JH3M!^@H K^)Y(!H<T,SP+YQ50)L8(W
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M)/4DDU!!HEA:WOVNU@^SRD!6$3%58#. 5'!QD]J (M:M=0O(TBM#;*@.YFE
M)SSP 58?UJ+PU$MMHIS$\7[V1V++M#$G)95VK@'L,"MJB@#D=UQ,8[^3[1%I
M-W<Q3C]XK29)4(?55)"< D@'L,XUO$TD(T.>*9X!YV$ F(PW()QG@G .,\9Q
M5B+1-.AG25+?!1MZ(78HC>JIG:#]!6A0!RW@Q95CO-TPEBR@#;D.6&=V-O\
M"?E(SSR1VJCK<\UUK,Z6%_!-/)B.U">:S6\BCY_N?)[X8CWR.*Z^"RBM[FXN
M%WM+.1O9V)X&< >@&3Q[FJT^A:=/<I=?9Q%<H2RS0DQL">IR,9S[T .O(]0G
MTWRHA:BY<8DW$E /;*G/;J*S/#EG):ZAJ!G3,Y$:/,B!(VQNPH 1<D9Y//4#
M/%=%10!R^HO=WMW>7&GK+Y,*&UG.Y/F Y;8K=QG&21GWP*U))[:+PR)(YHS
MUJ%B>Z;Y6RN%WGWXS4MQHNGW4SRRP$M)CS LC*LG;YE!PW''(-7@ H    X
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M23^- %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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80 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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M_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\
M%4E% "_:+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q
M5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E%
M "_:+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB
M^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:
M+[_GM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[
M0?\ ?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_G
MM!_WY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\
M?D__ !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_W
MY/\ \51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__
M !5)10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\
M\51]HOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)
M10 OVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]
MHOO^>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 O
MVB^_Y[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]HOO^
M>T'_ 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_
MY[0?]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]HOO^>T'_
M 'Y/_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?
M]^3_ /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \51]HOO^>T'_ 'Y/
M_P 5244 +]HOO^>T'_?D_P#Q5'VB^_Y[0?\ ?D__ !5)10 OVB^_Y[0?]^3_
M /%4?:+[_GM!_P!^3_\ %4E% "_:+[_GM!_WY/\ \53[:ZN3>I#,\3(Z,WRQ
ME2""/<^M1T0?\A2#_KE)_-* -6BBB@ HHHH **** "N>TC_D#V?_ %R6NAKG
MM(_Y ]G_ -<EH N4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1!_P A2#_KE)_-**(/^0I!_P!<I/YI0!JT444 %%%% !1110 5SVD?
M\@>S_P"N2UT-<]I'_('L_P#KDM %RBBB@ HHHH **** "BBB@ HHHH ****
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M\^\__?(_QH\\_P#/O/\ ]\C_ !J:B@"'SS_S[S_]\C_&CSS_ ,^\_P#WR/\
M&IJ* (?//_/O/_WR/\:///\ S[S_ /?(_P :FHH A\\_\^\__?(_QH\\_P#/
MO/\ ]\C_ !J:B@"'SS_S[S_]\C_&CSS_ ,^\_P#WR/\ &IJ* (?//_/O/_WR
M/\:///\ S[S_ /?(_P :FHH A\\_\^\__?(_QH\\_P#/O/\ ]\C_ !J:B@"'
MSS_S[S_]\C_&CSS_ ,^\_P#WR/\ &IJ* (?//_/O/_WR/\:///\ S[S_ /?(
M_P :FHH A\\_\^\__?(_QH\\_P#/O/\ ]\C_ !J:B@"'SS_S[S_]\C_&CSS_
M ,^\_P#WR/\ &IJ* (?//_/O/_WR/\:///\ S[S_ /?(_P :FHH A\\_\^\_
M_?(_QH\\_P#/O/\ ]\C_ !J:B@"'SS_S[S_]\C_&CSS_ ,^\_P#WR/\ &IJ*
M (?//_/O/_WR/\:///\ S[S_ /?(_P :FHH A\\_\^\__?(_QH\\_P#/O/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M #SA_P"_A_PHW7/_ #SA_P"_A_PH EHJ+=<_\\X?^_A_PHW7/_/.'_OX?\*
M):*BW7/_ #SA_P"_A_PHW7/_ #SA_P"_A_PH EHJ+=<_\\X?^_A_PHW7/_/.
M'_OX?\* ):*BW7/_ #SA_P"_A_PHW7/_ #SA_P"_A_PH EHJ+=<_\\X?^_A_
MPHW7/_/.'_OX?\* ):*BW7/_ #SA_P"_A_PHW7/_ #SA_P"_A_PH EHJ+=<_
M\\X?^_A_PHW7/_/.'_OX?\* ):*BW7/_ #SA_P"_A_PHW7/_ #SA_P"_A_PH
M EHJ+=<_\\X?^_A_PHW7/_/.'_OX?\* ):*BW7/_ #SA_P"_A_PHW7/_ #SA
M_P"_A_PH EHJ+=<_\\X?^_A_PHW7/_/.'_OX?\* ):*BW7/_ #SA_P"_A_PH
MW7/_ #SA_P"_A_PH EHJ+=<_\\X?^_A_PHW7/_/.'_OX?\* ):*BW7/_ #SA
M_P"_A_PHW7/_ #SA_P"_A_PH EHJ+=<_\\X?^_A_PHW7/_/.'_OX?\* ):*B
MW7/_ #SA_P"_A_PHW7/_ #SA_P"_A_PH EHJ+=<_\\X?^_A_PHW7/_/.'_OX
M?\* ):*BW7/_ #SA_P"_A_PHW7/_ #SA_P"_A_PH EHJ+=<_\\X?^_A_PHW7
M/_/.'_OX?\* ):*BW7/_ #SA_P"_A_PHW7/_ #SA_P"_A_PH EHJ+=<_\\X?
M^_A_PK(O?$2Z?JT=A<0HF]0QF,AVKG/7C/:IE.,%>3)E)15Y&Y16%>^(3I^L
M1V5S'!'$T>\REVXZX' ]JU]UQ_SSA_[^'_"E&<9-I= C-2;2Z$U<=.;B\^(,
M499=ML05'8*%R?QYKK-US_SSA_[^'_"N;L0[^.=1<)&TB1#^,X'"@\XK&NK\
MJ\T8UE?E7F=31!_R%(/^N4G\TJ+=<_\ /.'_ +^'_"G6AE.JP^8J >5)C:Q/
M=?85TG0;%%%% !7G'C#4]<M?%(CLM5AAA\H!$^W01+$2I^:17^8_-M/&1MR.
MM>CUY3XL:YU/5+HS:9>V]NR^6=VF6KR%1P661Y W/4''% 'JB$F-22"<#)'0
MTZF18\E,9QM&,T^@ KGM(_Y ]G_UR6NAKGM(_P"0/9_]<EH N4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%1SRK#;RRLP540L2>@P*YKP]XFN]4U%;2XAA *,^]
M 0>.V*RE5C&2B]V9RJ1C)1>[.J'49KR?4[V>^OY9;B3S&4E%. /E!.!Q7I^H
MS_9--N9SD>7$S#CVKS#3].N-3E>&W"&1(S(0S8R!UKBQS;<8(X\8VW&"$N[@
M7"V@!8F*%8V)[D$G^M>EV&JV>HO-':R%V@P'.WC\#WZ5Y7M;8'P=I.,^]==X
M$8>9?+GG:AQ^=882K)5.7N8X6HU4MW.JU&X^R:9=7 .#'$S Y[XX_6N=\%6$
ML<$]_*>)_E3/4@'DY^O\JD\:7TUM8Q6T87R[G<)"1SQ@\5K:#;/9Z%:0R AP
MFY@>Q)SC]:[G:>(M_*OQ9V_'7_PK\S1H@_Y"D'_7*3^:440?\A2#_KE)_-*Z
MSI-6BBB@ KRGQ58:1?:O<WFOV]]H\S,L:WDUJEQ!M7(^5QD+N&",X*D9KU:N
M!U-?!6FZS*GB+4IKR^!\SR[]I)4C#'("H!L ].* .\CQY:[3D8&#ZTZJNG:C
M9:K8QW>GSI/;/PKITXX(QV/M5J@ KGM(_P"0/9_]<EKH:Y[2/^0/9_\ 7):
M+E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5;.T8E#N8METSA5P/<D <T >F:3IL&EVCQP,[>=*\[L[[B6<Y//Z?05>ID9
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M *Y2?S2BB#_D*0?]<I/YI78=1JT444 %><^*KS5'\02M83HT8C6.W,+6IC+
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MYI6QJ:M%%% !1110 4444 %<]I'_ "![/_KDM=#7/:1_R![/_KDM %RBBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ?\ $T@_ZY2?S2H?LD']S_QX_P"-/M(8XM5A*+C,4F>2>ZT ;%%%% !1110
M4444 %<]I'_('L_^N2UT-<]I'_('L_\ KDM %RBBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **CGF2VMY)Y3B.-2S?05Y_%XMU)-1-PTID@W
M']P0 -O8<=#[UA5KPI-*74QJUHTVE+J>B454TS4(M4L4NH00&X*GJI[BIOM5
MO]J^S>?']HQN\K=\V/7%:J2:33W-5)-7):***H84444 %%%(S*HRS*H]2<4
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MK7_O\O\ C1_:-C_S_6O_ '^7_&@"RP#*58!E/!!Y!J);6WC@:!((TB8$,BJ
M"#]*C_M&Q_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&E9"L<Y?>!X),M8W!B)/W)1
MN4#V/6MO3=$L],LGMD3S!*/WK/SOXQT[#VJQ_:-C_P _UK_W^7_&C^T;'_G^
MM?\ O\O^-91H4XRYHHSC1IQ?,D+:V-I8JXM;>.$.<ML&,FK%5O[1L?\ G^M?
M^_R_XT?VC8_\_P!:_P#?Y?\ &M4DE9&B26B+-%5O[1L?^?ZU_P"_R_XT?VC8
M_P#/]:_]_E_QIC+-%5O[1L?^?ZU_[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&
MQ_Y_K7_O\O\ C1_:-C_S_6O_ '^7_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]
M:_\ ?Y?\: +-%5O[1L?^?ZU_[_+_ (T?VC8_\_UK_P!_E_QH LT56_M&Q_Y_
MK7_O\O\ C1_:-C_S_6O_ '^7_&@"S15;^T;'_G^M?^_R_P"-']HV/_/]:_\
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M(MD,K121K*C;"20P W97'K@4FJ3V&GR3P'R5GO )BD\FR-\%59@W9@,=/04
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MOWL\,&D22&6)8S%A6G/R$D8&[V/%,ET33IIWEDM\EVW.@=@CGU9 =I/U%:%
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M -D<<8'%6+K2[.]E$LT;>:%V[XY&C8KZ$J1D>QJQ!!%;0)!!&L<2#"HHP *
M.%\/H_\ PDL30S0,I>1Y$A:/RP"&SM .[.[:1ZACG&*VO%=U'$MNIO8$$9,L
M]LYD)DCP1G$>6P#@],<5N2V44UY!<R;V>#)C7<=H)!&['K@D9]S45_I-AJD9
M2]M(I@5VY8?-CTR.10!4T&/4XM(*WGE&7+&$$N, DE5;=D@ 8'<X%9::=>1^
M(K*6^CCE)E>1!;(!Y1VL"6;RP=O.,%LG(ZUU%O"+>%8E>1E7H9'+-^9Y-24
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ML8P<#GC-;O@3P#K/AOQ/<:AJ%ZLZ%)4:99LFZ+R;PSKL!R!QEF;'0<5Z510
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
9110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Nov. 03, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 138.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 03, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">138.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">138.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp236808_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp236808_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp236808_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp236808_exfilingfees.htm">dp236808_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp236808_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp236808_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2024": 3,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236808_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236808_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236808_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236808_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236808_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236808_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000950103-25-014144-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-014144-xbrl.zip
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M4IP8,XC@.MUU!VOQG*2R6HCGE<9G)97+;<PC-9ID3H<A35C(R @0 G8ZYF)
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7;5!+!08      0 ! $<   "!"P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>dp236808_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-03</startDate>
            <endDate>2025-11-03</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-03</startDate>
            <endDate>2025-11-03</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-11-03</startDate>
            <endDate>2025-11-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">1000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">1000000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">138.10</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">1000000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">138.10</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">138.10</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">1000000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
